Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

10.56USD
16 Aug 2019
Change (% chg)

$1.76 (+20.00%)
Prev Close
$8.80
Open
$9.13
Day's High
$11.06
Day's Low
$8.65
Volume
50,815
Avg. Vol
18,614
52-wk High
$15.49
52-wk Low
$4.11

About

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $28.94
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.76 -- --
ROI: -41.68 8.94 14.48
ROE: -41.68 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates